Manulife MIM International Equity Index Fund
As of December 31, 2024
Volatility meter
Low | High |
Annualized compound returns
Returns | Fund (%) | Benchmark (%) |
---|---|---|
3 mo (%) | -2.27 | -2.18 |
1 year (%) | 13.10 | 13.20 |
2 year (%) | 14.44 | 14.13 |
3 year (%) | 6.51 | 6.13 |
5 year (%) | 7.12 | 6.91 |
Fund characteristics
Underlying Fund: Manulife Investment Management International Equity Index Pooled Fund
Composition
as of 11/30/2024
Asset breakdown | % | ||
Foreign Equity | 95.53% | ||
Cash & Equivalents | 4.42% | ||
Other | 0.04% | ||
Equity industry
as of 11/30/2024
Industry sector | % | ||
Financials | 20.74% | ||
Industrials | 16.90% | ||
Health Care | 12.30% | ||
Consumer Discretionary | 10.00% | ||
Information Technology | 8.33% | ||
Consumer Staples | 8.04% | ||
Materials | 5.99% | ||
Communication Services | 4.73% | ||
Energy | 3.37% | ||
Utilities | 3.15% | ||
Real Estate | 1.65% | ||
Cash & Other Assets | 4.79% |
Geographic split
as of 11/30/2024
Country | % | ||
Japan | 21.79% | ||
United Kingdom | 13.78% | ||
Switzerland | 9.74% | ||
France | 9.58% | ||
Germany | 8.66% | ||
Australia | 7.31% | ||
Netherlands | 5.17% | ||
United States | 4.14% | ||
Denmark | 3.13% | ||
Other | 16.70% |
Example: $10,000 investment
Top Holdings
within the underlying fundas of 11/30/2024
Holdings | % |
---|---|
United States of America (Government) 0% 11-FEB-2025 | 3.40 |
Novo Nordisk A/S | 2.00 |
ASML Holding NV | 1.60 |
SAP SE | 1.40 |
Nestle SA | 1.30 |
AstraZeneca PLC | 1.20 |
Novartis AG | 1.20 |
Roche Holding AG | 1.20 |
Shell PLC | 1.20 |
Toyota Motor Corp | 1.00 |
Total | 15.50 |
Benchmark
MSCI EAFE Index (CAD) |
Note: All rates of return are presented before the deduction of investment management fees (IMF) and taxes, and after the deduction of underlying fund operating expenses and segregated fund operating expenses where they are not included in the IMF. Operating expenses may include, but are not limited to, legal, audit, trustee, custodial and fund valuation fees.
The returns prior to the effective date of the Fund (if applicable) have been determined using past performance of the underlying investments. Performance histories are not indicative of future performance. The growth chart is an example only and used only to illustrate the effects of the compound growth rate and does not reflect actual future values of any fund or returns on investment of any fund.
This fund page is provided for informational purposes only and does not constitute, and should not be interpreted as, advice of any nature. Individual investment goals and objectives should be considered when evaluating specific investments and trading strategies.
This information has been compiled from sources considered reliable, but no representations or warranties, express or implied, are made by Manulife, its affiliates or any other person as to its accuracy, completeness or correctness. Manulife shall not assume any liability or responsibility for any direct, indirect or other loss or damage or any other consequence whatsoever of any person acting or not acting in reliance on any information contained herein.
Source: Lipper, an LSEG Company.